{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T12:45:14Z","timestamp":1785501914019,"version":"3.56.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s40744-020-00229-0","type":"journal-article","created":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T10:03:10Z","timestamp":1597658590000},"page":"825-836","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study"],"prefix":"10.1007","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6189-5328","authenticated-orcid":false,"given":"Ennio","family":"Lubrano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Scriffignano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Belen","family":"Azuaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan D.","family":"Ca\u00f1ete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Massimo","family":"Perrotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,17]]},"reference":[{"key":"229_CR1","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJMra1505557","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376:957\u201370. https:\/\/doi.org\/10.1056\/NEJMra1505557.","journal-title":"N Engl J Med"},{"key":"229_CR2","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jaad.2015.05.001","volume":"73","author":"AP Villani","year":"2015","unstructured":"Villani AP, Rouzaud M, Sevrain M, et al. Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: systematic review and meta-analysis. J Am Acad Dermatol. 2015;73:242\u20138. https:\/\/doi.org\/10.1016\/j.jaad.2015.05.001.","journal-title":"J Am Acad Dermatol"},{"key":"229_CR3","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.3899\/jrheum.190054","volume":"46","author":"E Lubrano","year":"2019","unstructured":"Lubrano E, Scriffignano S, Perrotta FM. Psoriatic arthritis, psoriatic disease, or psoriatic syndrome? J Rheumatol. 2019;46:1428\u201330. https:\/\/doi.org\/10.3899\/jrheum.190054.","journal-title":"J Rheumatol"},{"key":"229_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-020-00202-x","author":"JD Ca\u00f1ete","year":"2020","unstructured":"Ca\u00f1ete JD, Tasende JAP, Laserna FJR, Castro SG, Queiro R. The impact of comorbidity on patient-reported outcomes in psoriatic arthritis: a systematic literature review. Rheumatol Ther. 2020. https:\/\/doi.org\/10.1007\/s40744-020-00202-x(Epub ahead of print).","journal-title":"Rheumatol Ther"},{"key":"229_CR5","doi-asserted-by":"crossref","unstructured":"Lubrano E, Scriffignano S, Perrotta FM (2020) Multimorbidity and comorbidity in psoriatic arthritis\u2014a perspective. Exp Rev Clin Immunol, article in press.","DOI":"10.1080\/1744666X.2021.1825941"},{"key":"229_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10067-018-4332-7","volume":"38","author":"S Scriffignano","year":"2019","unstructured":"Scriffignano S, Perrotta FM, De Socio A, Lubrano E. Role of comorbidities in spondyloarthritis including psoriatic arthritis. Clin Rheumatol. 2019;38:3\u201310. https:\/\/doi.org\/10.1007\/s10067-018-4332-7.","journal-title":"Clin Rheumatol."},{"key":"229_CR7","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.rdc.2015.07.008","volume":"41","author":"ME Husni","year":"2015","unstructured":"Husni ME. Comorbidities in psoriatic arthritis. Rheum Dis Clin North Am. 2015;41:677\u201398.","journal-title":"Rheum Dis Clin North Am"},{"key":"229_CR8","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1136\/annrheumdis-2015-208174","volume":"75","author":"A Molto","year":"2016","unstructured":"Molto A, Etcheto A, van der Heijde D, et al. Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the inter- national cross-sectional ASAS-COMOSPA study. Ann Rheum Dis. 2016;75:1016\u201323.","journal-title":"Ann Rheum Dis"},{"key":"229_CR9","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s10067-018-4004-7","volume":"37","author":"R Queiro","year":"2018","unstructured":"Queiro R, Canete JD. Impact of cardiovascular risk factors on the achievement of therapeutic goals in psoriatic arthritis: is there any association? Clin Rheumatol. 2018;37:661\u20136. https:\/\/doi.org\/10.1007\/s10067-018-4004-7.","journal-title":"Clin Rheumatol"},{"key":"229_CR10","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.berh.2018.09002","volume":"32","author":"A Molto","year":"2018","unstructured":"Molto A, Dougados M. Comorbidities in spondyloarthritis including psoriatic arthritis. Best Pract Res Clin Rheumatol. 2018;32:390\u2013400. https:\/\/doi.org\/10.1016\/j.berh.2018.09002.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"229_CR11","first-page":"512","volume":"37","author":"E Lubrano","year":"2019","unstructured":"Lubrano E, Scriffignano S, De Socio A, Perrotta FM. Analysis of potential determinants for a treat-to- target strategy in psoriatic arthritis patients from a real-world setting. Clin Exp Rheumatol. 2019;37:512.","journal-title":"Clin Exp Rheumatol"},{"key":"229_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24090","author":"AM Orbai","year":"2019","unstructured":"Orbai AM, Perin J, Gorlier C. Determinants of patient-reported psoriatic arthritis impact of disease: an analysis of the association with gender in 458 patients from 14 countries. Arthritis Care Res (Hoboken). 2019. https:\/\/doi.org\/10.1002\/acr.24090[Epub ahead of print].","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"229_CR13","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3899\/jrheum.181471","volume":"47","author":"W Bavi\u00e8re","year":"2020","unstructured":"Bavi\u00e8re W, Deprez X, Houvenagel E, et al. Association between comorbidities and quality of life in psoriatic arthritis: results from a multicentric cross-sectional study. J Rheumatol. 2020;47:369\u201376. https:\/\/doi.org\/10.3899\/jrheum.181471.","journal-title":"J Rheumatol"},{"key":"229_CR14","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3899\/jrheum.121500","volume":"40","author":"JA Husted","year":"2013","unstructured":"Husted JA, Thavaneswaran A, Chandran V, Gladman DD. Incremental effects of comorbidity on quality of life in patients with psoriatic arthritis. J Rheumatol. 2013;40:1349\u201356. https:\/\/doi.org\/10.3899\/jrheum.121500.","journal-title":"J Rheumatol"},{"key":"229_CR15","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1136\/annrheumdis-2013-204448","volume":"74","author":"L Eder","year":"2015","unstructured":"Eder L, Thavaneswaran A, Chandran V, Cook RJ, Gladman DD. Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis. Ann Rheum Dis. 2015;74:813\u20137. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204448.","journal-title":"Ann Rheum Dis"},{"key":"229_CR16","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1093\/rheumatology\/kev239","volume":"54","author":"H Radner","year":"2015","unstructured":"Radner H, Yoshida K, Frits M, et al. The impact of multimorbidity status on treatment response in rheumatoid arthritis patients initiating disease-modifying anti-rheumatic drugs. Rheumatology (Oxford). 2015;54:2076\u201384. https:\/\/doi.org\/10.1093\/rheumatology\/kev239.","journal-title":"Rheumatology (Oxford)"},{"key":"229_CR17","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.3899\/jrheum.141534","volume":"42","author":"H Radner","year":"2015","unstructured":"Radner H, Yoshida K, Hmamouchi I, Dougados M, Smolen JS, Solomon DH. Treatment patterns of multimorbid patients with rheumatoid arthritis: results from an international cross-sectional study. J Rheumatol. 2015;42:1099\u2013104. https:\/\/doi.org\/10.3899\/jrheum.141534.","journal-title":"J Rheumatol"},{"key":"229_CR18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1136\/annrheumdis-2019-216151","volume":"79","author":"KL Winthrop","year":"2020","unstructured":"Winthrop KL, Weinblatt ME, Bathon J. Unmet need in rheumatology: reports from the Targeted Therapies Meeting 2019. Ann Rheum Dis. 2020;79:88\u201393. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216151(Epub 2019 Oct 29).","journal-title":"Ann Rheum Dis"},{"key":"229_CR19","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, CASPAR Study Group, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54:2665\u2013733. https:\/\/doi.org\/10.1002\/art.21972.","journal-title":"Arthritis Rheum"},{"key":"229_CR20","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/art.23568","volume":"59","author":"PJ Healy","year":"2008","unstructured":"Healy PJ, Helliwell PS. Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthritis Rheum. 2008;59:686\u201391. https:\/\/doi.org\/10.1002\/art.23568.","journal-title":"Arthritis Rheum"},{"key":"229_CR21","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s40744-019-00171-w","volume":"6","author":"E Lubrano","year":"2019","unstructured":"Lubrano E, Perrotta FM, Scriffignano S, et al. Sustained very low disease activity and remission in psoriatic arthritis patients. Rheumatol Ther. 2019;6:521\u20138. https:\/\/doi.org\/10.1007\/s40744-019-00171-w.","journal-title":"Rheumatol Ther"},{"issue":"1","key":"229_CR22","doi-asserted-by":"publisher","first-page":"e001170","DOI":"10.1136\/rmdopen-2020-001170","volume":"6","author":"E Lubrano","year":"2020","unstructured":"Lubrano E, Scriffignano S, Azuaga AB, Ramirez J, Canete J, Perrotta FM. Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: association with disease activity and quality of life indices. RMD Open. 2020;6(1):e001170. https:\/\/doi.org\/10.1136\/rmdopen-2020-001170.","journal-title":"RMD Open"},{"key":"229_CR23","first-page":"123","volume":"11","author":"R Ranza","year":"1993","unstructured":"Ranza R, Marchesoni A, Calori G, et al. The Italian version of the functional disability index of the health assessment questionnaire. a reliable instrument for multicenter studies on rheumatoid arthritis. Clin Exp Rheumatol. 1993;11:123\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"229_CR24","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.3899\/jrheum.150595","volume":"42","author":"E Lubrano","year":"2015","unstructured":"Lubrano E, Perrotta FM, Parsons WJ, et al. Patient's global assessment as an outcome measure for psoriatic arthritis in clinical practice: a surrogate for measuring low disease activity? J Rheumatol. 2015;42:2332\u20138. https:\/\/doi.org\/10.3899\/jrheum.150595.","journal-title":"J Rheumatol"},{"key":"229_CR25","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1136\/annrheumdis-2015-207507","volume":"75","author":"MM Schoels","year":"2016","unstructured":"Schoels MM, Aletaha D, Alasti F, et al. Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score. Ann Rheum Dis. 2016;75:811\u20138. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207507.","journal-title":"Ann Rheum Dis."},{"key":"229_CR26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/ard.2008.102053","volume":"69","author":"LC Coates","year":"2010","unstructured":"Coates LC, Fransen J, Helliwel PS. Defining disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis. 2010;69:48\u201353. https:\/\/doi.org\/10.1136\/ard.2008.102053.","journal-title":"Ann Rheum Dis"},{"key":"229_CR27","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1136\/annrheumdis-2014-205207","volume":"73","author":"L Gossec","year":"2014","unstructured":"Gossec L, de Wit M, Kiltz U, EULAR PsAID Taskforce, et al. A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative. Ann Rheum Dis. 2014;73:1012\u20139. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205207.","journal-title":"Ann Rheum Dis"},{"key":"229_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00296-018-4195-x","volume":"39","author":"A Gottlieb","year":"2019","unstructured":"Gottlieb A, Gratacos J, Dikranian A, et al. Treatment patterns, unmet need, and impact on patient-reported outcomes of psoriatic arthritis in the United States and Europe. Rheumatol Int. 2019;39:121\u201330. https:\/\/doi.org\/10.1007\/s00296-018-4195-x.","journal-title":"Rheumatol Int"},{"key":"229_CR29","doi-asserted-by":"publisher","first-page":"e000585","DOI":"10.1136\/rmdopen-2017-000585","volume":"5","author":"JS Smolen","year":"2019","unstructured":"Smolen JS, Gladman D, McNeil HP, et al. Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study. RMD Open. 2019;5:e000585. https:\/\/doi.org\/10.1136\/rmdopen-2017-000585.","journal-title":"RMD Open"},{"key":"229_CR30","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrrheum.2013.212","volume":"10","author":"H Radner","year":"2014","unstructured":"Radner H, Yoshida K, Smolen JS, Solomon DH. Multimorbidity and rheumatic conditions-enhancing the concept of comorbidity. Nat Rev Rheumatol. 2014;10:252\u20136. https:\/\/doi.org\/10.1038\/nrrheum.2013.212.","journal-title":"Nat Rev Rheumatol."},{"key":"229_CR31","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1136\/annrheumdis-2018-214140","volume":"78","author":"C Gorlier","year":"2019","unstructured":"Gorlier C, Orbai AM, Puyraimond-Zemmour D, et al. Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries. Ann Rheum Dis. 2019;78:201\u20138. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214140.","journal-title":"Ann Rheum Dis"},{"key":"229_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.4081\/reumatismo.2020.1266","volume":"72","author":"FM Perrotta","year":"2020","unstructured":"Perrotta FM, Delle Sedie A, Scriffignano S, et al. Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12\/23 and IL-17inhibitors. A multicenter prospective study. Reumatismo. 2020;72:52\u20139. https:\/\/doi.org\/10.4081\/reumatismo.2020.1266.","journal-title":"Reumatismo"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-020-00229-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-020-00229-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-020-00229-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,16]],"date-time":"2021-08-16T23:49:11Z","timestamp":1629157751000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-020-00229-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,17]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["229"],"URL":"https:\/\/doi.org\/10.1007\/s40744-020-00229-0","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,17]]},"assertion":[{"value":"22 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"No funding or sponsorship was received for this study or publication of this article. All authors had full access to all of the data in this study and take complete responsibility for the integrity of the data and accuracy of the data analysis.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authorship"}},{"value":"All authors should have made substantial contributions to all of these sections: conception and design of the study, acquisition of data, analysis and interpretation of data, drafting the article, revising it critically for important intellectual content, and final approval of the version to be submitted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authorship Contributions"}},{"value":"Ennio Lubrano, Silvia Scriffignano, Ana Belen Azuaga, Julio Ramirez, Juan D. Ca\u00f1ete, and Fabio Massimo Perrotta have nothing to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study. The study was approved by the Institutional Review Board of the University of Molise.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethics Guidelines"}},{"value":"The datasets generated during and\/or analyzed during the current study are not publicly available but are available from the corresponding author on reasonable request.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}}]}}